MONDANELLI, GIADA
 Distribuzione geografica
Continente #
NA - Nord America 3.123
EU - Europa 2.042
AS - Asia 1.901
Continente sconosciuto - Info sul continente non disponibili 298
SA - Sud America 271
AF - Africa 56
OC - Oceania 2
Totale 7.693
Nazione #
US - Stati Uniti d'America 2.991
SG - Singapore 860
IT - Italia 791
VN - Vietnam 272
CN - Cina 249
HK - Hong Kong 238
RO - Romania 237
IE - Irlanda 215
BR - Brasile 196
RU - Federazione Russa 169
DE - Germania 157
FR - Francia 122
FI - Finlandia 70
GB - Regno Unito 62
CA - Canada 60
IN - India 42
BD - Bangladesh 37
SE - Svezia 35
KR - Corea 31
CZ - Repubblica Ceca 30
AR - Argentina 27
BE - Belgio 26
MX - Messico 24
NL - Olanda 24
JP - Giappone 22
TR - Turchia 21
IQ - Iraq 20
PL - Polonia 20
ES - Italia 17
UA - Ucraina 17
PK - Pakistan 15
CO - Colombia 13
VE - Venezuela 13
AT - Austria 12
EG - Egitto 12
NI - Nicaragua 12
EC - Ecuador 10
CR - Costa Rica 9
IL - Israele 9
SA - Arabia Saudita 9
UZ - Uzbekistan 9
ZA - Sudafrica 9
CH - Svizzera 8
ID - Indonesia 8
MA - Marocco 8
TH - Thailandia 7
GT - Guatemala 6
CI - Costa d'Avorio 5
CL - Cile 5
GR - Grecia 5
JM - Giamaica 5
JO - Giordania 5
MY - Malesia 5
NP - Nepal 5
PH - Filippine 5
PR - Porto Rico 5
SC - Seychelles 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
CW - ???statistics.table.value.countryCode.CW??? 4
KZ - Kazakistan 4
LT - Lituania 4
AZ - Azerbaigian 3
DK - Danimarca 3
ET - Etiopia 3
EU - Europa 3
HR - Croazia 3
LB - Libano 3
UY - Uruguay 3
AM - Armenia 2
BH - Bahrain 2
DZ - Algeria 2
EE - Estonia 2
GP - Guadalupe 2
HU - Ungheria 2
KE - Kenya 2
KG - Kirghizistan 2
KW - Kuwait 2
LK - Sri Lanka 2
MD - Moldavia 2
NG - Nigeria 2
PS - Palestinian Territory 2
PY - Paraguay 2
SN - Senegal 2
SV - El Salvador 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AU - Australia 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
BZ - Belize 1
CG - Congo 1
CU - Cuba 1
DJ - Gibuti 1
GD - Grenada 1
GE - Georgia 1
HN - Honduras 1
IR - Iran 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 7.391
Città #
Singapore 670
Perugia 442
Ashburn 290
San Jose 283
Chandler 275
Hong Kong 238
Dublin 215
Bucharest 202
Dong Ket 152
Redmond 130
Santa Clara 120
Boardman 99
Council Bluffs 98
San Mateo 91
Munich 87
Los Angeles 79
Beijing 67
Moscow 63
New York 60
Altamura 58
Medford 48
Lauterbourg 47
Dallas 45
Princeton 45
The Dalles 45
Lawrence 43
Ho Chi Minh City 38
Wilmington 36
Des Moines 31
Seoul 30
Turku 29
Andover 26
Brussels 26
Pisa 26
Atlanta 25
Chicago 24
North Bergen 24
Hanoi 23
Orem 23
Ann Arbor 22
Falls Church 22
Phoenix 22
São Paulo 22
Montreal 21
Rome 20
Tokyo 20
Helsinki 19
Brno 17
Milan 16
Nuremberg 16
Chiajna 15
Piscataway 15
Redwood City 15
San Francisco 15
Warsaw 15
Amsterdam 14
Denver 14
Măgurele 13
Olomouc 13
Frankfurt am Main 12
Norwalk 12
Brooklyn 11
Buffalo 11
Chennai 11
Dearborn 11
Florence 11
Izmir 11
Lappeenranta 11
London 11
Managua 11
Poplar 11
Columbus 10
Stockholm 10
Manchester 9
Saint Petersburg 9
Toronto 9
Baghdad 8
Bologna 8
Curitiba 8
Houston 8
Johannesburg 8
Mexico City 8
Rio de Janeiro 8
San José 8
Seattle 8
Vicenza 8
Fremont 7
Spoleto 7
Boston 6
Falkenstein 6
Haiphong 6
Mumbai 6
Philadelphia 6
Querétaro 6
Riverbank 6
Riyadh 6
San Diego 6
Tashkent 6
Woodbridge 6
Abidjan 5
Totale 5.045
Nome #
Class IA PI3Ks regulate subcellular and functional dynamics of IDO1 221
A Relay Pathway between Arginine and Tryptophan Metabolism Confers Immunosuppressive Properties on Dendritic Cells 215
Allosteric modulation of metabotropic glutamate receptor 4 activates IDO1-dependent, immunoregulatory signaling in dendritic cells 212
Assessment of TILs, IDO-1, and PD-L1 in resected non-small cell lung cancer: an immunohistochemical study with clinicopathological and prognostic implications 207
In-depth characterization of phenolic profiling of Moraiolo extra-virgin olive oil extract and initial investigation of the inhibitory effect on Indoleamine-2,3-Dioxygenase (IDO1) enzyme 206
Amino-acid sensing and degrading pathways in immune regulation 205
Engagement of Nuclear Coactivator 7 by 3-Hydroxyanthranilic Acid Enhances Activation of Aryl Hydrocarbon Receptor in Immunoregulatory Dendritic Cells 199
Distinct roles of immunoreceptor tyrosine-based motifs in immunosuppressive indoleamine 2,3-dioxygenase 1. 191
Amino acid metabolism as drug target in autoimmune diseases 186
Artocarpus tonkinensis extract inhibits LPS-triggered inflammation markers and suppresses RANKL-induced osteoclastogenesis in RAW264.7 181
Identification of a 2-propanol analogue modulating the non-enzymatic function of indoleamine 2,3-dioxygenase 1 180
Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation 179
IL‐35Ig–expressing dendritic cells induce tolerance via Arginase 1 169
A back-door insight into the modulation of Src kinase activity by the polyamine spermidine 164
A novel mutation of indoleamine 2,3-dioxygenase 1 causes a rapid proteasomal degradation and compromises protein function 159
3-hydroxy-L-kynurenamine is an immunomodulatory biogenic amine 159
LPS-conditioned dendritic cells confer endotoxin tolerance contingent on tryptophan catabolism 154
Deficiency of immunoregulatory indoleamine 2,3-dioxygenase 1 in juvenile diabetes 151
Immunoregulatory interplay between arginine and tryptophan metabolism in health and disease 147
Epacadostat stabilizes the apo-form of IDO1 and signals a pro-tumorigenic pathway in human ovarian cancer cells 146
Aryl hydrocarbon Receptor and RelB control long term expression of Indoleamine 2,3-dioxygenase-1 in endotoxin tolerance 146
Pharmacologic Induction of Endotoxin Tolerance in Dendritic Cells by L-Kynurenine 144
Antigen-specific immunoregulation by IL-35Ig-transfected dendritic cells 142
Indoleamine 2,3-dioxygenase 2 immunohistochemical expression in a resected non-small cell lung cancer series 141
Novel mutations in the WFS1 gene are associated with Wolfram syndrome and systemic inflammation 136
Ectopic expression of IL-35Ig by dendritic cells induces tolerance via Arginase 1. 135
Indoleamine 2,3-Dioxygenase 2 Immunohistochemical Expression in Resected Human Non-small Cell Lung Cancer: A Potential New Prognostic Tool 131
Forced IDO1 expression in dendritic cells restores immunoregulatory signalling in autoimmune diabetes 129
Effect of Probiotic Administration on Serum Tryptophan Metabolites in Pediatric Type 1 Diabetes Patients 124
Pathogenetic Interplay Between IL-6 and Tryptophan Metabolism in an Experimental Model of Obesity 124
Effects of probiotic administration on immune responses of children and adolescents with type 1 diabetes to a quadrivalent inactivated influenza vaccine 123
The catalytic inhibitor epacadostat can affect the non-enzymatic function of IDO1 122
Islet antigen-pulsed dendritic cells expressing ectopic IL-35Ig protect nonobese diabetic mice from autoimmune diabetes. 121
The signaling function of IDO1 incites the malignant progression of mouse B16 melanoma 109
Induction of immunosuppressive functions and NF-kappa B by FLIP in monocytes 108
Reinstalling immune regulatory tryptophan catabolism in juvenile diabetes via interleukin 6 receptor blockade 107
Loss of IDO1 Expression From Human Pancreatic -Cells Precedes Their Destruction During the Development of Type 1 Diabetes 107
The landscape of AhR regulators and coregulators to fine-tune AhR functions 106
Wolfram syndrome, a rare neurodegenerative disease: From pathogenesis to future treatment perspectives 105
Polyamines and Kynurenines at the Intersection of Immune Modulation 103
Membrane Localization and Phosphorylation of Indoleamine 2,3-Dioxygenase 2 (IDO2) in A549 Human Lung Adenocarcinoma Cells: First Steps in Exploring Its Signaling Function 102
Current Challenges for IDO2 as Target in Cancer Immunotherapy 102
Modulation of Indoleamine 2,3-Dioxygenase 1 During Inflammatory Bowel Disease Activity in Humans and Mice 101
Unrevealing the Role of TLRs in the Pathogenesis of Autoimmune Disease by Using Mouse Model of Diabetes 99
SLC6A4 DNA Methylation Levels and Serum Kynurenine/Tryptophan Ratio in Eating Disorders: A Possible Link with Psychopathological Traits? 97
Sensing of an HIV-1-Derived Single-Stranded RNA-Oligonucleotide Induces Arginase 1-Mediated Tolerance 96
Differentiation of Myeloid-derived Suppressor Cells from Murine Bone Marrow and Their Co-culture with Splenic Dendritic Cells 96
The immune regulation in cancer by the amino acid metabolizing enzymes ARG and IDO 95
The Proteasome Inhibitor Bortezomib Controls Indoleamine 2,3-Dioxygenase 1 Breakdown and Restores Immune Regulation in Autoimmune Diabetes. 91
Chromatographic measurement of 3-hydroxyanthranilate 3,4-dioxygenase activity reveals that edaravone can mitigate the formation of quinolinic acid through a direct enzyme inhibition 88
Reply to Han et al.: On track for an IDO1-based personalized therapy in autoimmunity 83
Epigenetic Modeling of Jumping Translocations of 1q Heterochromatin in Acute Myeloid Leukemia After 5'-Azacytidine Treatment 81
Challenges in the design of reliable immuno-oncology mouse models to inform drug development 80
Immune Checkpoint Molecules, Personalized Immunotherapy, and Autoimmune Diabetes 74
Decoding the Complex Crossroad of Tryptophan Metabolic Pathways 66
Opportunities and challenges in drug discovery targeting metabotropic glutamate receptor 4 65
Assessment of TILs, IDO-1 and PD-L1 in resected non small cell lung cancer: an immunohistochemical study with clinicopathological and prognostic implications. 64
The double life of serotonin metabolites: in the mood for joining neuronal and immune systems 55
Rewriting the dendritic cell code in cancer—from subset identity to immunotherapeutic design 34
Ligand-induced conformations and dynamic allosteric motions of IDO1 affecting the recruitment of a protein signaling partner 30
Totale 7.693
Categoria #
all - tutte 31.865
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.865


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022730 0 0 0 0 28 14 4 115 152 148 76 193
2022/2023901 47 177 19 67 93 96 1 43 300 12 33 13
2023/2024482 33 58 14 8 6 6 126 7 29 20 63 112
2024/20251.219 24 83 49 85 110 79 109 155 191 56 185 93
2025/20262.520 138 126 131 316 375 237 446 144 263 194 105 45
2026/2027902 63 194 185 366 94 0 0 0 0 0 0 0
Totale 7.693